495
Participants
Start Date
February 8, 2022
Primary Completion Date
April 6, 2023
Study Completion Date
July 6, 2023
UNAIR Inactivated COVID-19 Vaccine
UNAIR Inactivated Covid-19 Vaccine contains S protein of SARS-CoV-2 virus, Aluminium hydroxide gel, 10 mM L-Histidine buffer, 0.005% Tween Polysorbate 80, and 0.9% Sodium chloride. Vaccine will be prepared in vial (1 ml per vial). One vial will be used for one injection only. The vial should be shaken well before injection.
CoronaVac Biofarma COVID-19 Vaccine
Control vaccine in this study is existing CoronaVac-BioFarma inactivated COVID-19 vaccine which has been used widely in Indonesia.
RECRUITING
Dr. Soetomo General Hospital, Surabaya
Collaborators (1)
Indonesia-MoH
OTHER_GOV
Universitas Airlangga
OTHER
Bioxis Pharmaceuticalls
INDUSTRY
Dr. Soetomo General Hospital
OTHER_GOV